US Opens Duty Probe Into Chinese Medicinal Chemical
The U.S. Department of Commerce said Friday it will examine a pharmaceutical compound imported from China to determine whether it has been subsidized and sold at less than fair value, potentially...To view the full article, register now.
Already a subscriber? Click here to view full article